Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Urbano Anido | Researchclopedia

Back to researchers

Urbano Anido

Universidade de Santiago de Compostela

165

Works

2,029

Citations

19

h-index

28

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Bladder and Urothelial Cancer Treatments Prostate Cancer Treatment and Research

Affiliations

Universitat Autònoma de Barcelona2011–2011

Universidade de Santiago de Compostela2009–2025

University Hospital Complex Of Vigo2009–2009

Hôpital Farhat Hached2016–2016

Complejo Hospitalario Universitario de Santiago2007–2025

Top Works

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles,Mark Kockx,et al.

2019560 citations

Renal cell carcinoma treatment

Urinary and Genital Oncology Studies

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Thomas Powles,Michiel S. van der Heijden,et al.

2020489 citations

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

Laura Muinelo‐Romay,María Vieito,et al.

2014102 citations

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab

Patricia Mondelo‐Macía,Jorge García,et al.

202161 citations

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

Jesús García-Donás,Albert Font,et al.

201750 citations

Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer.

Thomas Powles,Juergen E. Gschwend,et al.

201747 citations

Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

Juan Ruiz‐Bañobre,Aurea Molina-Díaz,et al.

202147 citations

High-Risk Endometrial Carcinoma Profiling Identifies TGF-β1 as a Key Factor in the Initiation of Tumor Invasion

Laura Muinelo‐Romay,Eva Colás,et al.

201144 citations

X-Ray Cross-Complementing Group 1 and Thymidylate Synthase Polymorphisms Might Predict Response to Chemoradiotherapy in Rectal Cancer Patients

María Jesús Lamas,Goretti Duran,et al.

201035 citations